MedAdvisor Limited (MDR.AX)
AUD 0.1
(0.0%)
AUD 0.1
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 2.69 Million AUD | 134.95% |
| 2023 | -7.71 Million AUD | 52.33% |
| 2022 | -16.18 Million AUD | 11.6% |
| 2021 | -18.31 Million AUD | -64.5% |
| 2020 | -11.13 Million AUD | -35.44% |
| 2019 | -8.21 Million AUD | -78.78% |
| 2018 | -4.59 Million AUD | -33.13% |
| 2017 | -3.45 Million AUD | -18.45% |
| 2016 | -2.91 Million AUD | -336.75% |
| 2015 | -667.55 Thousand AUD | 94.02% |
| 2014 | -11.16 Million AUD | -206.0% |
| 2013 | -3.64 Million AUD | -227.7% |
| 2012 | -1.11 Million AUD | -1077.77% |
| 2011 | -94.51 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | 2.69 Million AUD | 134.95% |
| 2024 Q4 | -245.34 Thousand AUD | 0.0% |
| 2024 Q2 | 8.17 Million AUD | 0.0% |
| 2023 Q2 | 5.76 Million AUD | 0.0% |
| 2023 FY | -7.71 Million AUD | 52.33% |
| 2023 Q4 | -14.19 Million AUD | 0.0% |
| 2022 FY | -16.18 Million AUD | 11.6% |
| 2022 Q2 | -6.94 Million AUD | 0.0% |
| 2022 Q4 | -9.24 Million AUD | 0.0% |
| 2021 FY | -18.31 Million AUD | -64.5% |
| 2021 Q4 | -10.57 Million AUD | 0.0% |
| 2021 Q2 | -6.87 Million AUD | 0.0% |
| 2020 FY | -11.13 Million AUD | -35.44% |
| 2020 Q4 | -5.78 Million AUD | 0.0% |
| 2020 Q2 | -5.34 Million AUD | 0.0% |
| 2019 Q2 | -4.57 Million AUD | 0.0% |
| 2019 FY | -8.21 Million AUD | -78.78% |
| 2019 Q4 | -3.63 Million AUD | 0.0% |
| 2018 Q2 | -2.31 Million AUD | 0.0% |
| 2018 FY | -4.59 Million AUD | -33.13% |
| 2018 Q4 | -2.28 Million AUD | 0.0% |
| 2017 Q2 | -2.03 Million AUD | 0.0% |
| 2017 FY | -3.45 Million AUD | -18.45% |
| 2017 Q4 | -1.41 Million AUD | 0.0% |
| 2016 FY | -2.91 Million AUD | -336.75% |
| 2016 Q2 | -929.45 Thousand AUD | 0.0% |
| 2016 Q4 | -1.98 Million AUD | 0.0% |
| 2015 FY | -667.55 Thousand AUD | 94.02% |
| 2015 Q1 | -2.79 Million AUD | 0.0% |
| 2015 Q3 | -166.88 Thousand AUD | 43.97% |
| 2015 Q4 | -260.36 Thousand AUD | -56.01% |
| 2015 Q2 | -297.83 Thousand AUD | 89.33% |
| 2014 Q3 | -2.79 Million AUD | 0.0% |
| 2014 FY | -11.16 Million AUD | -206.0% |
| 2014 Q4 | -2.79 Million AUD | 0.0% |
| 2014 Q2 | -2.79 Million AUD | -206.0% |
| 2014 Q1 | -911.93 Thousand AUD | 0.0% |
| 2013 Q3 | -911.93 Thousand AUD | 0.0% |
| 2013 Q4 | -911.93 Thousand AUD | 0.0% |
| 2013 Q2 | -911.93 Thousand AUD | -227.7% |
| 2013 Q1 | -278.28 Thousand AUD | 0.0% |
| 2013 FY | -3.64 Million AUD | -227.7% |
| 2012 FY | -1.11 Million AUD | -1077.77% |
| 2012 Q1 | -23.62 Thousand AUD | 0.0% |
| 2012 Q2 | -278.28 Thousand AUD | -1077.77% |
| 2012 Q3 | -278.28 Thousand AUD | 0.0% |
| 2012 Q4 | -278.28 Thousand AUD | 0.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2011 FY | -94.51 Thousand AUD | 0.0% |
| 2011 Q4 | -23.62 Thousand AUD | 0.0% |
| 2011 Q2 | -23.62 Thousand AUD | 0.0% |
| 2011 Q3 | -23.62 Thousand AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alcidion Group Limited | -7.64 Million AUD | 135.273% |
| Artrya Limited | -14.4 Million AUD | 118.729% |
| Beamtree Holdings Limited | -609 Thousand AUD | 542.849% |
| Cogstate Limited | 6.17 Million AUD | 56.309% |
| Careteq Limited | -1.92 Million AUD | 239.764% |
| Doctor Care Anywhere Group PLC | -16.36 Million AUD | 116.485% |
| Emyria Limited | -4.26 Million AUD | 163.266% |
| Global Health Limited | -1.76 Million AUD | 253.119% |
| HITIQ Limited | -2.55 Million AUD | 205.352% |
| Intelicare Holdings Limited | -3.1 Million AUD | 186.954% |
| ImExHS Limited | -2.59 Million AUD | 204.006% |
| Mach7 Technologies Limited | -1.76 Million AUD | 252.627% |
| Oakridge International Limited | -341.59 Thousand AUD | 889.518% |
| Opyl Limited | -3.22 Million AUD | 183.593% |
| PainChek Limited | -9.51 Million AUD | 128.347% |
| Pro Medicus Limited | 112.18 Million AUD | 97.596% |
| Resonance Health Limited | 593.95 Thousand AUD | -354.068% |
| Singular Health Group Ltd | -3.93 Million AUD | 168.55% |
| Total Brain Limited | -6.63 Million AUD | 140.669% |